Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Therapies for Gambiense HAT
NCT00330148Phase 3Terminated
- Sponsor
- Illumina
- Start
- Mar 2001
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of nifurtimox in human African trypanosomiasis (HAT), sponsored by Illumina. Started Mar 2001; status: terminated.
02
Drugs
nifurtimox
03
Conditions
human African trypanosomiasis (HAT)
Beyond the preview
Go deeper on NCT00330148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330148.